Feature Channels: Diabetes

Filters close
Released: 6-Dec-2023 3:05 PM EST
Young age at first menstrual cycle linked to heightened diabetes risk in mid-life
BMJ

Starting menstrual cycles at a young age—before the age of 13—is linked to a heightened risk of developing type 2 diabetes in mid-life, finds US research published online in the open access journal BMJ Nutrition Prevention & Health.

Newswise: Type 1 diabetes: B cell-derived natural antibodies suppress autoimmune pathogenesis
Released: 6-Dec-2023 5:05 AM EST
Type 1 diabetes: B cell-derived natural antibodies suppress autoimmune pathogenesis
University of Alabama at Birmingham

Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing Type 1 diabetes.

Released: 5-Dec-2023 10:05 AM EST
Under-the-skin implant could treat Type I diabetes
Cornell University

A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat Type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while avoiding the immunosuppression that typically stymies management of the disease.

Released: 4-Dec-2023 6:05 PM EST
Lipids and diabetes are closely linked
Université de Genève (University of Geneva)

While sugar is the most frequently named culprit in the development of type 2 diabetes, a better understanding of the role of fats is also essential.

Not for public release

This news release is embargoed until 4-Dec-2023 5:00 PM EST Released to reporters: 28-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Supplement lowers risk of higher glucose caused by blood-pressure drug
Released: 29-Nov-2023 12:05 PM EST
Supplement lowers risk of higher glucose caused by blood-pressure drug
UT Southwestern Medical Center

A dietary supplement developed by a UT Southwestern Medical Center researcher significantly reduced high blood sugar caused by a diuretic used to lower blood pressure while also correcting electrolyte imbalances, UTSW researchers report. The findings, published in Hypertension, could offer a solution for the serious side effects associated with this class of drugs.

Released: 28-Nov-2023 2:05 PM EST
NIH awards $2.6M to Wayne State to develop new filtration platform for insulin administration
Wayne State University Division of Research

A Wayne State University College of Engineering professor has received a $2.65 million award from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to develop a novel filtration platform to improve an advanced drug delivery device to optimize diabetes insulin treatments.

Newswise: A diabetes device that makes a lot of “Sense”
Released: 27-Nov-2023 3:05 PM EST
A diabetes device that makes a lot of “Sense”
Michigan Medicine - University of Michigan

A young patient's design helps people with diabetes live easier lives

20-Nov-2023 9:30 AM EST
Mount Sinai Researchers Find Testosterone Hormone Therapy for Transmasculine Individuals Is Safer Than Previously Thought
Mount Sinai Health System

A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of red blood cells, with the use of prescribed testosterone. However, Mount Sinai researchers have found that testosterone treatment may be safer than previously reported.

Newswise:Video Embedded he-has-never-stopped-fighting-for-me-the-legacy-of-innovative-diabetes-care-at-barnstable-brown
VIDEO
Released: 22-Nov-2023 9:05 AM EST
'He has never stopped fighting for me' — the legacy of innovative diabetes care at Barnstable Brown
University of Kentucky

“Just like any other parent who out of nowhere their child is suddenly ill, it pretty much takes your breath away. It is not something you know how to fix,” remembers Cindy Farmer.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Type 2 diabetes: a new disease mechanism uncovered
Released: 21-Nov-2023 8:05 AM EST
Type 2 diabetes: a new disease mechanism uncovered
Universite de Montreal

Published just before World Diabetes Day, work by Dr. May Faraj, director of the Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases at the Montreal Clinical Research Institute (IRCM) and full professor at the Department of Nutrition at the University of Montreal, highlight a new mechanism and a new role for LDL – commonly called bad cholesterol – in the development of type 2 diabetes, LDL already being involved in cardiovascular diseases in the human.

Not for public release

This news release is embargoed until 20-Nov-2023 5:00 PM EST Released to reporters: 14-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-Nov-2023 2:05 PM EST
UC Irvine-led study uncovers prevalence of diabetes among American Indian and Alaska Native communities
University of California, Irvine

In a first-of-its-kind study, researchers from the University of California, Irvine, led a study that estimated the prevalence of Type 1 and Type 2 diabetes among American Indian and Alaska Native (AI/AN) of all ages and found that the AI/AN population has a notably higher prevalence of Type 2 diabetes compared to the general U.S. population across all ages starting at 10 years of age.

Newswise: Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers
Released: 16-Nov-2023 8:05 AM EST
Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers
Case Western Reserve University

A combined $1.35 million from the Dr. Ralph and Marian Falk Medical Research Trust was awarded to two researchers from the Case Western Reserve University School of Medicine to advance their work on finding more effective treatments—and better options—for two debilitating diseases.

Released: 15-Nov-2023 11:20 AM EST
From Farm to Newsroom: The Latest Research and Features on Agriculture
Newswise

The world’s total population is expected to reach 9.9 billion by 2050. This rapid increase in population is boosting the demand for agriculture to cater for the increased demand. Below are some of the latest research and features on agriculture and farming in the Agriculture channel on Newswise.

Released: 15-Nov-2023 7:05 AM EST
World-first study to screen 20,000 UK adults for type 1 diabetes
University of Bristol

A world-first research programme that will identify adults at high risk of developing type 1 diabetes has opened for recruitment in the UK.

13-Nov-2023 10:05 AM EST
New York State Dooms Diabetes Sufferers to Amputations, Dialysis and Alzheimers by Cutting Funds for Proven Programs That Help Residents Lower Blood Sugar Levels
Health People

Expressing outrage over the state’s plan to kill programs well-proven to slash diabetes and other chronic disease, activists, providers and patients rallied outside the state Health Department in lower Manhattan today, World Diabetes Day, to protest state negligence that will clearly impose even worse chronic disease on low-income communities already reeling from the aftermath of Covid-19.

   
Newswise: Diabetes Alert Day - 2023
Released: 13-Nov-2023 10:05 AM EST
Diabetes Alert Day - 2023
Hackensack Meridian Health

Tuesday, November 14, is Diabetes Alert Day.

Newswise: Antibodies to Cow’s Milk Linked to Increased Risk of Cardiovascular Death
9-Nov-2023 4:05 AM EST
Antibodies to Cow’s Milk Linked to Increased Risk of Cardiovascular Death
University of North Carolina Health Care System

Analyses led by Corinne Keet, MD, PhD, at the University of North Carolina School of Medicine, of two longitudinal studies reveal how an increased level of an antibody called immunoglobin (IgE) to cow’s milk is associated to cardiovascular-related death.

Released: 7-Nov-2023 1:05 PM EST
MSU working to help promote success of Type 1 diabetes treatments with support from JDRF
Michigan State University

JDRF, the world’s largest nonprofit supporter of Type 1 diabetes research, has awarded a $750,000 grant to a team of Michigan State University researchers.

30-Oct-2023 9:00 AM EDT
Real-World Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients
American Society of Nephrology (ASN)

Compared with kidney transplant recipients who did not receive sodium-glucose cotransporter-2 inhibitors, those treated with the medications had lower risks of experiencing kidney transplant failure, kidney transplant rejection, major adverse cardiac events, all-cause mortality, and genitourinary infections.

Released: 3-Nov-2023 5:05 PM EDT
يشارك خبراء مايو كلينك هيلثكير أخبارًا سارة وأخرى سيئة حول الذبحة الصدرية
Mayo Clinic

تعد الذبحة الصدرية، وهي شعور بالانزعاج يصيب الصدر ناجم عن انخفاض تدفق الدم إلى القلب، عرضًا من أعراض مرض الشريان التاجي.

30-Oct-2023 9:00 AM EDT
Sotagliflozin Protects Kidney and Heart in Patients with Type 2 Diabetes and Chronic Kidney Disease
American Society of Nephrology (ASN)

Results from the phase 3 SCORED trial indicate that sotagliflozin protects kidney and heart health in individuals with type 2 diabetes and chronic kidney disease.

Released: 3-Nov-2023 11:05 AM EDT
Un experto de Mayo Clinic Healthcare comparte buenas y malas noticias sobre la angina
Mayo Clinic

La angina, un malestar en el pecho causado por la reducción del flujo sanguíneo al corazón, es un síntoma común de enfermedad de las arterias coronarias.

Released: 3-Nov-2023 11:00 AM EDT
Popular Weight Loss Drug Does Not Appear to Worsen Diabetic Eye Disease in Most Patients, New Study Suggests
American Academy of Ophthalmology (AAO)

New study shows that most people taking semaglutide do not develop diabetic retinopathy or experience a worsening of existing diabetic retinopathy.

Released: 3-Nov-2023 10:05 AM EDT
Human insulin less temperature-sensitive than previously thought
Cochrane

A new Cochrane review has found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration

Released: 2-Nov-2023 5:05 PM EDT
Dexamethasone Implants Could Preserve Vision Longer for Diabetic Macular Edema Patients
Sbarro Health Research Organization (SHRO)

Diabetic macular edema (DME) is a significant complication of diabetes, often leading to vision loss. A recent review paper published in the journal Pharmaceutics provides evidence-based recommendations on using intravitreal dexamethasone implants (DEX) for treating DME.

30-Oct-2023 9:00 AM EDT
Wildfire Air Pollution May Increase Risks of Hospitalization and Death Among Patients on Dialysis
American Society of Nephrology (ASN)

Among individuals receiving in-center hemodialysis treatment in Washington, Oregon, and California, exposure to wildfire-related air pollution was associated with elevated risks of hospitalization and mortality.

30-Oct-2023 9:00 AM EDT
Are Sodium-Glucose Cotransporter-2 Inhibitors Safe for Patients with Diabetes and Cancer?
American Society of Nephrology (ASN)

Investigators found that in patients with diabetes and cancer, sodium glucose cotransporter-2 inhibitors were associated with a higher risk of diabetic ketoacidosis and fracture and a lower risk of acute kidney injury and urinary tract infection compared with glucagon-like peptide 1 receptor agonists.

30-Oct-2023 9:00 AM EDT
Simple Automated Tool Prompts Physicians to Screen Patients with Diabetes for Kidney Disease
American Society of Nephrology (ASN)

• A tool that provides an automated prompt to physicians increased kidney disease screening in patients with type 2 diabetes. • Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5.

Released: 1-Nov-2023 7:05 PM EDT
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
University of Chicago Medical Center

A new study led by researchers at UChicago Medicine and Indiana University suggests that an existing drug could be repurposed to treat type 1 diabetes, potentially reducing dependence on insulin.

Newswise: Repurposed drug offers new potential for managing type 1 diabetes
Released: 1-Nov-2023 4:05 PM EDT
Repurposed drug offers new potential for managing type 1 diabetes
Indiana University

A new study published in Cell Reports Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The study's findings' suggest repurposing of the drug α-difluoromethylornithine (DFMO) may open doors to innovative therapies.

Released: 1-Nov-2023 3:05 PM EDT
Focus on Your Sight and Health to Ward Off Vision Loss from Diabetes
American Society of Retina Specialists

An often silent condition that can steal vision, diabetic retinopathy is a complication of diabetes that may have no noticeable symptoms in the early stages and is the leading cause of irreversible blindness in working-age Americans.

Released: 1-Nov-2023 3:05 PM EDT
Preste atención a su vista y salud para prevenir la pérdida de visión causada por la diabetes
American Society of Retina Specialists

La retinopatía diabética, una enfermedad a menudo silenciosa que puede robarle la visión, es una complicación de la diabetes que pudiera no tener síntomas perceptibles en las primeras etapas, y es la principal causa de ceguera irreversible en los estadounidenses de edad de laboral.

Released: 1-Nov-2023 12:05 PM EDT
Wake Forest University School of Medicine Launches $100 Million Philanthropic Campaign for Research
Wake Forest University School of Medicine

Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist, the academic core of Advocate Health, are launching their largest campaign for research. Designed with health equity at the forefront, funds raised in this campaign will transform health care for patients, communities and the next generation of health care leaders by integrating research with clinical care while enhancing the speed with which new ideas move from research labs to patients' bedsides and beyond.

Newswise: News Tip: November Is National Diabetes Month; Johns Hopkins Experts Available for Interviews
Released: 1-Nov-2023 9:00 AM EDT
News Tip: November Is National Diabetes Month; Johns Hopkins Experts Available for Interviews
Johns Hopkins Medicine

With so many people in the U.S. at risk of developing diabetes, it is critical for the general public to understand that they can take action to prevent it, such as being more active and making small changes in their diet. Diabetes experts at Johns Hopkins Medicine are available to be interviewed throughout November about this important topic and to clear up common misconceptions surrounding this condition.

Released: 31-Oct-2023 1:05 PM EDT
High insulin levels directly linked to pancreatic cancer
University of British Columbia

First detailed explanation of why people with obesity and Type 2 diabetes are at an increased risk of pancreatic cancer

Released: 31-Oct-2023 6:05 AM EDT
American Thyroid Association® Announces New Board of Directors
American Thyroid Association

Michael McDermott, MD Installed as President Christopher McCabe, PhD Installed as Secretary

Released: 30-Oct-2023 9:00 AM EDT
Is High Urinary Albumin Linked to Sub-Clinical Cardiovascular Disease in People with Type 2 Diabetes?
American Society of Nephrology (ASN)

Imaging tests in individuals with type 2 diabetes without symptoms of cardiovascular disease indicated that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary artery microcalcifications.

Newswise: IU scientists part of NIH-funded national consortium focused on improving Alzheimer’s disease diagnoses
Released: 27-Oct-2023 11:05 AM EDT
IU scientists part of NIH-funded national consortium focused on improving Alzheimer’s disease diagnoses
Indiana University

Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer's disease. The multi-institution effort is funded by a five-year, $9 million grant from the National Institute on Aging, part of the National Institutes of Health, that will establish the Alzheimer's Diagnosis in Older Adults with Chronic Conditions (ADACC) Network.

25-Oct-2023 11:00 AM EDT
Intermittent fasting is safe, effective for those with Type 2 diabetes
University of Illinois Chicago

More weight lost among people who fasted, compared to calorie restriction

Newswise: Case Western Reserve University researcher awarded $3.5 million federal grant
Released: 26-Oct-2023 8:00 AM EDT
Case Western Reserve University researcher awarded $3.5 million federal grant
Case Western Reserve University

A researcher from the Case Western Reserve University Frances Payne Bolton School of Nursing has been awarded a $3.5 million federal grant for research to improve sleep health and glucose management in young adults with type 1 diabetes. Positive findings could lead to adding the intervention in current care protocols.

Released: 25-Oct-2023 3:05 PM EDT
Research finds potential target for cardiovascular disease in diabetes
Michigan Medicine - University of Michigan

Targeting NETs could reduce the risk of heart attack and stroke for diabetic patients



close
2.6761